Earnings197ATAUNS Laboratories,Inc.
Tauns Laboratories Reports Q3 Revenue of 10.7 billion, Down 39%
TOKYO, May 14 (Pulse News Wire) – Tauns Laboratories, Inc. (197A.T) reported non-consolidated results for Q3 FY2026 (ending June 2026).
Revenue was ¥10.7 billion (-39.4% YoY). operating profit was ¥3,509 million (-62.4%). net profit attributable to shareholders was ¥2,443 million (-63.2%).
Total assets stood at ¥41.4 billion with an equity ratio of 39.3%. The company declared an annual dividend of ¥14 per share. The full-year forecast for the current fiscal year is revenue of ¥15.0 billion.
Financial results — FY2026/6 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥10,663M | -39.4% |
| Operating profit | ¥3,509M | -62.4% |
| Net profit | ¥2,443M | -63.2% |
Next period forecast
Revenue
¥15,048M
-19.2%Op. profit
¥4,368M
-47.1%Net profit
¥5,692M
-9.9%Source: TDNet filing · Figures in millions of yen
End of article